4 Other than being on GLP-1s, higher risk patients include: those in the dose-escalation phase and those with upper GI symptoms (eg, nausea, vomiting, dyspepsia, abdominal distension, and abdominal discomfort/pain). 4 And obviously, other high-risk group includes patients with comorbidities associated with delayed gastric emptying (eg, poorly controlled diabetes, Parkinsons disease, bowel dysmotility) as well as those on other drugs that slow gastric emptying (eg, opioids, tricyclic antidepressants, marijuana, alcohol)
and H.S
Severe organ dysfunction (kidney or liver failure) might slow peptide clearance and is screened for
But first, lets look at semaglutide use for losing weight when you dont have a diabetes diagnosis
As a retrospective cohort analysis, it is inherently subject to biases such as selection bias
Glutathione Injections Glutathione injections are used for skin lightening and also detoxification purposes